Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06460038
PHASE2
Tenapanor in Synucleinopathy-Related Constipation
Sponsor: Cedar Valley Digestive Health Center
View on ClinicalTrials.gov
Summary
Investigation of tenapanor as a potential treatment for synucleinopathy-associated constipation
Official title: Efficacy and Safety of Tenapanor in Synucleinopathy-Related Constipation
Key Details
Gender
All
Age Range
50 Years - 89 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-01-01
Completion Date
2027-03
Last Updated
2025-02-10
Healthy Volunteers
No
Conditions
Interventions
DRUG
Tenapanor
Inhibitor of NHE3
DRUG
Placebo
Placebo drug
Locations (1)
Cedar Valley Digestive Health Center
Waterloo, Iowa, United States